Cailin Sibley is a medical advisor at Eli Lilly and Company. Dr. Sibley joined Lilly in 2018 and completed her residency training in rheumatology at UCSF Medical Center. She received her M.D. from David Geffen School of Medicine at UCLA in 2002 and her Bachelor of Science in Biology from California Institute of Technology in 1997.
In oncology, precision medicine is leading a paradigm shift away from a “one size fits all”…